| Name | Steward Organization | Suggested Domain | Suggested Domain Description | Cde Group | Classification |
|---|---|---|---|---|---|
| Antiplatelet agent in hospital type | NINDS | Treatment |
Treatment for all conditions |
NIH CDEs |
|
| # | Datatype |
|---|---|
|
|
Value List |
| # | Permissible value | Value meaning name | Value meaning definition |
|---|---|---|---|
|
|
Aspirin | Aspirin | Aspirin |
|
|
Aspirin/Dipyridamole (in separate formulations or as Aggrenox) | Aspirin/Dipyridamole (in separate formulations or as Aggrenox) | Aspirin/Dipyridamole (in separate formulations or as Aggrenox) |
|
|
Cilostazol | Cilostazol | Cilostazol |
|
|
Clopidogrel (Plavix) | Clopidogrel (Plavix) | Clopidogrel (Plavix) |
|
|
Other, specify | Other, specify | Other, specify |
| # | Definition |
|---|---|
|
|
Type(s) of antiplatelet agents received during the acute hospital stay |
| # | Designation |
|---|---|
|
|
Antiplatelet agent in hospital type |
| # | Identifier | Origin | Version |
|---|---|---|---|
|
|
C14632 | NINDS | 3 |
|
|
AntiplatAgentInHospTyp | BRICS Variable Name | N/A |
|
|
HXVHcdJ5uCr | NLM CDEs | 12-02-2025-download |